These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 23383049

  • 1. Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: outcomes of a nationwide measles-rubella mass vaccination campaign.
    Honarvar B, Moghadami M, Moattari A, Emami A, Odoomi N, Bagheri Lankarani K.
    PLoS One; 2013; 8(1):e55043. PubMed ID: 23383049
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
    Hayford K, Mutembo S, Carcelen A, Matakala HK, Munachoonga P, Winter A, Wanyiri JW, Searle K, Mwansa FD, Mwiche A, Phiri C, Book C, Thuma PE, Moss WJ.
    Vaccine; 2019 Apr 17; 37(17):2387-2393. PubMed ID: 30905529
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran.
    Pourabbas B, Ziyaeyan M, Alborzi A, Mardaneh J.
    Int J Infect Dis; 2008 Jan 17; 12(1):43-6. PubMed ID: 17950020
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
    Hachiya M, Miyano S, Mori Y, Vynnycky E, Keungsaneth P, Vongphrachanh P, Xeuatvongsa A, Sisouk T, Som-Oulay V, Khamphaphongphane B, Sengkeopaseuth B, Pathammavong C, Phounphenghak K, Kitamura T, Takeda M, Komase K.
    PLoS One; 2018 Jan 17; 13(3):e0194931. PubMed ID: 29596472
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of immunity against rubella in Iranian after mass campaign for measles-rubella vaccination on December 2003.
    Hamkar R, Jalilvand S, Mokhtari-Azad T, Jelyani KN, Nategh R.
    Am J Infect Control; 2006 Nov 17; 34(9):588-92. PubMed ID: 17097454
    [Abstract] [Full Text] [Related]

  • 15. Seroprevalence of anti-rubella and anti-measles antibodies in women at the verge of marriage in Iran.
    Zahraei SM, Mokhtari-Azad T, Izadi S, Mohammadi M, Sabouri A.
    Vaccine; 2020 Jan 10; 38(2):235-241. PubMed ID: 31668816
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rubella and measles seroprevalence among women of childbearing age, Argentina, 2002.
    Dayan GH, Panero MS, Urquiza A, Molina M, Prieto S, Del Carmen Perego M, Scagliotti G, Galimberti D, Carroli G, Wolff C, Bi D, Bellini W, Icenogle J, Reef S.
    Epidemiol Infect; 2005 Oct 10; 133(5):861-9. PubMed ID: 16181506
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Measles and rubella immunity in the population of Bhutan, 2017.
    Wangchuk S, Nogareda F, Tshering N, Khandu L, Pelden S, Wannemuehler K, Wangdi S, Wangchuk U, Mulders M, Tamang T, Patel MK.
    Vaccine; 2019 Oct 08; 37(43):6463-6469. PubMed ID: 31500970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.